About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Brain Cancer Clinical Trials in Seattle | 64 Studies

Clinical Trials Brain CancerSeattle

Brain Cancer Clinical Trials in Seattle

Find 64 clinical trials for brain cancer near Seattle, Washington. Connect with research centers in your area.

All Brain Cancer trials nationwide All trials in Seattle

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 41-60 of 64 trials

CompletedA Study of Ribociclib and Everolimus Following Radiation Therapy in Children With Newly Diagnosed Non-biopsied Diffuse Pontine Gliomas (DIPG) and RB+ Biopsied DIPG and High Grade Gliomas (HGG)In this research study, we want to learn about the safety of the study drugs, ribociclib and everolimus, when given together at different doses after radiation therapy.NCT03355794·Washington D.C., District of Columbia and 6 others TerminatedTopotecan in Treating Young Patients With Neoplastic Meningitis Due to Leukemia, Lymphoma, or Solid TumorsRATIONALE: Drugs used in chemotherapy, such as topotecan, work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing.NCT00112619·San Francisco, California and 10 others

Brain Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedA Study of DSP-7888 Dosing Emulsion in Combination With Bevacizumab in Patients With Recurrent or Progressive Glioblastoma Following Initial TherapyThis is an event driven, adaptive design, a randomized, active-controlled, multicenter, open-label, parallel groups, Phase 3 study of DSP-7888 Dosing Emulsion plus Bevacizumab…NCT03149003·Birmingham, Alabama and 60 others

CompletedTemozolomide Plus Lomustine Followed by Radiation Therapy in Treating Patients With High-Grade Malignant GliomaRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00006024·Birmingham, Alabama and 234 others

TerminatedPalbociclib Isethionate in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System TumorsThis phase I trial studies the side effects and best dose of palbociclib isethionate in treating younger patients with central nervous system tumors that have grown, come back, or…NCT02255461·Los Angeles, California and 10 others

TerminatedMK0752 in Treating Young Patients With Recurrent or Refractory CNS CancerRATIONALE: MK0752 may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.NCT00572182·San Francisco, California and 11 others

CompletedEffect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)The study is a prospective, randomly controlled pivotal trial, designed to test the efficacy and safety of a medical device, the NovoTTF-100A, as an adjuvant to the best standard…NCT00916409·Birmingham, Alabama and 88 others

CompletedClinical Benefit of Using Molecular Profiling to Determine an Individualized Treatment Plan for Patients With High Grade GliomaThis is a 2 strata pilot trial within the Pacific Pediatric Neuro-Oncology Consortium (PNOC).NCT03739372·San Diego, California and 11 others

CompletedThe PRECISE Trial: Study of IL13-PE38QQR Compared to GLIADEL Wafer in Patients With Recurrent Glioblastoma MultiformeThe purpose of the PRECISE trial is to determine whether overall survival duration, safety, and quality of life are improved for patients treated with IL13-PE38QQR compared to…NCT00076986·Birmingham, Alabama and 59 others

CompletedCilengitide in Treating Younger Patients With Recurrent or Progressive High-Grade Glioma That Has Not Responded to Standard TherapyThis phase II trial studies how well cilengitide works in treating younger patients with recurrent or progressive high-grade glioma that has not responded to standard therapy.NCT00679354·Oakland, California and 19 others

CompletedPositron Emission Tomography Using Fluorothymidine F 18 in Finding Recurrent Disease in Patients With GliomasRATIONALE: Diagnostic procedures, such as positron emission tomography using fluorothymidine F 18, may be effective in finding recurrent disease in patients with gliomas.NCT00276770·Seattle, Washington

CompletedRadiation Therapy (RT) and Temozolomide (TMZ) in Treating Patients With Newly Diagnosed Glioblastoma or GliosarcomaRATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells.NCT00304031·Fairbanks, Alaska and 350 others

TerminatedAminolevulinic Acid During Surgery in Treating Patients With Malignant Brain TumorsThis phase I trial is studying the side effects and best dose of aminolevulinic acid during surgery in treating patients with malignant brain tumors.NCT01148966·Seattle, Washington

TerminatedVaccine Therapy With Bevacizumab Versus Bevacizumab Alone in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by SurgeryThis randomized phase II trial studies how well giving vaccine therapy with or without bevacizumab works in treating patients with recurrent glioblastoma multiforme that can be…NCT01814813·Anchorage, Alaska and 416 others

RecruitingLorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK FusionThe goal of this study is to determine the response of the study drug loratinib in treating children who are newly diagnosed high-grade glioma with a fusion in ALK or ROS1.NCT06333899·Aurora, Colorado and 17 others

TerminatedImatinib Mesylate With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed or Recurrent GliomaPhase I/II trial to estimate the maximum tolerated dose of imatinib mesylate in newly diagnosed brain stem gliomas and recurrent high grade gliomas and to assess the effectiveness…NCT00021229·San Francisco, California and 9 others

CompletedTemozolomide, Vincristine, and Irinotecan in Treating Young Patients With Refractory Solid TumorsRATIONALE: Drugs used in chemotherapy, such as temozolomide, vincristine, and irinotecan, work in different ways to stop the growth of tumor cells, either by killing the cells or…NCT00138216·Birmingham, Alabama and 17 others

CompletedVorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord TumorsThis phase I trial is studying the side effects and best dose of vorinostat when given together with temozolomide in treating young patients with relapsed or refractory primary…NCT01076530·Chicago, Illinois and 8 others

WithdrawnStudying Cerebrospinal Fluid Proteins and Angiogenesis Proteins in Young Patients With Newly Diagnosed Central Nervous System TumorsRATIONALE: Studying samples of cerebrospinal fluid from patients with cancer in the laboratory may help doctors identify biomarkers related to cancer.NCT00897858·Washington D.C., District of Columbia and 7 others

CompletedPhase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed GlioblastomaThis 2-arm, randomized, phase III study will investigate the efficacy and safety of the addition of rindopepimut (an experimental cancer vaccine that may act to promote…NCT01480479·Birmingham, Alabama and 222 others

PreviousPage 3 of 4Next

Other Conditions in Seattle

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia